Skip to content
UniqueBaseEN
For HumanFor AI ↗
Companies

Promaxo

Visit website ↗
Snapshot

As of Nov 1, 2026, UniqueBase lists 1 funding record for Promaxo; the latest is $1.43M (Series C) on Oct 22, 2026.

Funding records
1
Latest round
$1.43M · Series C
Consideration (USD)
—
Total raised (reported)
—
Rows with a source link
1 of 1
Profile
Stable identifier
UB-C11451
Country
United States
Source record updated
Oct 24, 2026
Snapshot captured
Nov 1, 2026
English updated
Nov 1, 2026
Original name

Promaxo

Translation dates do not change the dates of the underlying facts.

Overview

Promaxo is the FDA-cleared point-of-care MRI platform for prostate interventions.

Funding

Funding

Amounts as reported; USD estimates shown only when they match
Latest round
$1.4M
2026-10 · Series C
Records
1
1 month · all drawn

Data noteListed 1 funding record. Latest funding: $1.43M (Series C), Oct 22, 2026.

Funding events by monthUSD estimate
Funding events by monthEach dot is one funding record on its month. An empty month has no recorded round: it is not filled with zero, and the dots are not connected. Amounts are reconciled USD estimates and are not summed.2026-10$500K$1M$1.5M2026-10 funding Series C $1.4M
Each dot is one funding record on its month. An empty month has no recorded round: it is not filled with zero, and the dots are not connected. Amounts are reconciled USD estimates and are not summed.
DateFunding estimateConsideration (USD)InvestorsSources
Oct 22, 2026$1.43M · Series C— 1 source Source ↗

Select ▸ on a row to see its source brief and links.

Team, products & investors

Team

No published people profiles are linked yet.

Products

No published product profiles are linked yet.

Investors & institutions

No published investor profiles are linked yet.

Other connected profiles

Promaxo completes Series C financingNews ↗

Explore

United StatesCountry ↗
Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

Promaxo is the FDA-cleared point-of-care MRI platform for prostate interventions.

JSON ↗Markdown ↗